Myocardial 'no-reflow'—diagnosis, pathophysiology and treatment
In acute ST-segment elevation myocardial infarction (STEMI), improvement in reperfusion
strategies has contributed to improvement in mortality. Nonetheless up to 40–50% of …
strategies has contributed to improvement in mortality. Nonetheless up to 40–50% of …
[引用][C] Myocardial'no-reflow'―Diagnosis, pathophysiology and treatment
DTL WONG, R PURI, JD RICHARDSON… - International journal …, 2013 - pascal-francis.inist.fr
Myocardial 'no-reflow' ― Diagnosis, pathophysiology and treatment CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
Myocardial'no-reflow'-Diagnosis, pathophysiology and treatment
DTL Wong, R Puri, JD Richardson… - International …, 2013 - research.monash.edu
In acute ST-segment elevation myocardial infarction (STEMI), improvement in reperfusion
strategies has contributed to improvement in mortality. Nonetheless up to 40-50% of patients …
strategies has contributed to improvement in mortality. Nonetheless up to 40-50% of patients …
Myocardial 'no-reflow'—Diagnosis, pathophysiology and treatment
DTL Wong, R Puri… - International …, 2013 - internationaljournalofcardiology.com
In acute ST-segment elevation myocardial infarction (STEMI), improvement in reperfusion
strategies has contributed to improvement in mortality. Nonetheless up to 40–50% of …
strategies has contributed to improvement in mortality. Nonetheless up to 40–50% of …
Myocardial'no-reflow'--diagnosis, pathophysiology and treatment.
DT Wong, R Puri, JD Richardson… - … Journal of Cardiology, 2013 - europepmc.org
In acute ST-segment elevation myocardial infarction (STEMI), improvement in reperfusion
strategies has contributed to improvement in mortality. Nonetheless up to 40-50% of patients …
strategies has contributed to improvement in mortality. Nonetheless up to 40-50% of patients …
Myocardial'no-reflow'-Diagnosis, pathophysiology and treatment
T Wong, R Puri, J Richardson, M Worthley… - 2013 - digital.library.adelaide.edu.au
In acute ST-segment elevation myocardial infarction (STEMI), improvement in reperfusion
strategies has contributed to improvement in mortality. Nonetheless up to 40-50% of patients …
strategies has contributed to improvement in mortality. Nonetheless up to 40-50% of patients …
Myocardial'no-reflow'--diagnosis, pathophysiology and treatment
DTL Wong, R Puri, JD Richardson… - International …, 2013 - pubmed.ncbi.nlm.nih.gov
In acute ST-segment elevation myocardial infarction (STEMI), improvement in reperfusion
strategies has contributed to improvement in mortality. Nonetheless up to 40-50% of patients …
strategies has contributed to improvement in mortality. Nonetheless up to 40-50% of patients …
Myocardial 'no-reflow'—Diagnosis, pathophysiology and treatment
DTL Wong, R Puri, JD Richardson, MI Worthley… - International Journal of …, 2013 - infona.pl
In acute ST-segment elevation myocardial infarction (STEMI), improvement in reperfusion
strategies has contributed to improvement in mortality. Nonetheless up to 40–50% of …
strategies has contributed to improvement in mortality. Nonetheless up to 40–50% of …
Myocardial'no-reflow'-Diagnosis, pathophysiology and treatment
T Wong, R Puri, J Richardson, M Worthley… - 2013 - hekyll.services.adelaide.edu.au
In acute ST-segment elevation myocardial infarction (STEMI), improvement in reperfusion
strategies has contributed to improvement in mortality. Nonetheless up to 40-50% of patients …
strategies has contributed to improvement in mortality. Nonetheless up to 40-50% of patients …
[引用][C] Myocardial 'no-reflow'—Diagnosis, pathophysiology and treatment
DTL Wong, R Puri, JD Richardson… - International Journal of …, 2013 - cir.nii.ac.jp
Myocardial ‘no-reflow’ — Diagnosis, pathophysiology and treatment | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …